Dr Richard Clarkson



Prosiectau fel Prif Ymchwiliwr
null null 1 o 8 null null

The role of Bcl3 in mammary carcinogenesis - Cyllidwr:Breast Cancer Research Trust (01.02.2006 - 31.01.2010)
Sensitizing to radiotherapy: Pre clinical evaluation of a novel indication for adjuvant Bcl3i - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2015 - 31.12.2016)
KSBM076 - Cyllidwr:Osteotronix Ltd (01.09.2009 - 25.12.2009)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 3 null null

Human gammadelta T cells for immunotherapy of breast cancer - Cyllidwr:Tenovus (01.10.2011 - 30.06.2015)
RCUK Fellowships - Cyllidwr:Engineering and Physical Sciences Research Council (01.06.2005 - 31.03.2011)
Advancing analogues of a novel cFlip inhibitor which sensitises breast cancer cells and stem cells to TRAIL - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2015 - 30.09.2016)
Design synthesis and evaluation of cFlip inhibitors as novel anticancer agents - Cyllidwr:Tiziana Pharma Ltd (06.05.2015 - 31.12.2017)
Discovery of Bdi3 inhibitors for the potential treatment of metastatic cancer - Cyllidwr:Cancer Research Wales (01.10.2013 - 30.09.2016)

Diweddarwyd y tro diwethaf ar 2020-09-08 am 04:03